image
Healthcare - Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
IKT - STOCK-BASED COMPENSATION

Stock-based Compensation IKT - Inhibikase Therapeutics, Inc.

image
500 K
LAST VALUE
-42.86%
2 YEAR CAGR
-4.88%
5 YEAR CAGR
0.00%
10 YEAR CAGR